UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042762
Receipt number R000048811
Scientific Title Survey of real-world evidence in treatment of patients with CML who desire for bearing children
Date of disclosure of the study information 2020/12/15
Last modified on 2024/03/07 09:07:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey of real-world evidence in treatment of patients with CML who desire for bearing children

Acronym

Survey of real-world evidence in treatment of patients with CML who desire for bearing children (preg-CML/JAPAN study)

Scientific Title

Survey of real-world evidence in treatment of patients with CML who desire for bearing children

Scientific Title:Acronym

Survey of real-world evidence in treatment of patients with CML who desire for bearing children

Region

Japan


Condition

Condition

Chronic Myelogenous Leukemia (CML)

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Investigation of real-world evidence for pregnancy in young female patient with CML

Basic objectives2

Others

Basic objectives -Others

Retrospective observational study for CML treatment and pregnancy/delivery

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Investigation of real-world evidence for pregnancy in young female patient with CML

Key secondary outcomes

Relation between CML treatment and pregnancy/delivery.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

45 years-old >=

Gender

Female

Key inclusion criteria

1) Female parients with CML, who are/were treated at hematology department in Japan.
2) Diagnosed as chronic-phase CML between 1/1/2002 and 30/11/2020.
3) Diagnosed age was 45 years or younger.

Key exclusion criteria

none

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Kondo

Organization

Aiiku Hospital

Division name

Blood Disorders Center

Zip code

064-0804

Address

South 4 West 25, Chuo-ku, Sapporo

TEL

+81-11-563-2211

Email

kondo@aiiku-hp.or.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Kondo

Organization

Aiiku Hospital

Division name

Blood Disorders Center

Zip code

064-0804

Address

South 4 West 25, Chuo-ku, Sapporo

TEL

+81-11-563-2211

Homepage URL


Email

kondo@aiiku-hp.or.jp


Sponsor or person

Institute

"Investigation of real-world evidence for pregnancy in young female patient with CML" Study Group

Institute

Department

Personal name



Funding Source

Organization

Pfizer Health Research Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The institutional review boards of Aiiku Hospital

Address

South 4 West 25, Chuo-ku, Sapporo

Tel

+81-11-563-2211

Email

aiiku-rinri@aiiku-hp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

70

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 10 Month 28 Day

Date of IRB

2020 Year 10 Month 29 Day

Anticipated trial start date

2020 Year 12 Month 12 Day

Last follow-up date

2021 Year 11 Month 30 Day

Date of closure to data entry

2022 Year 03 Month 03 Day

Date trial data considered complete

2022 Year 03 Month 31 Day

Date analysis concluded

2022 Year 03 Month 31 Day


Other

Other related information

Retrospective observational study for CML treatment and pregnancy/delivery in young female patients with CML


Management information

Registered date

2020 Year 12 Month 15 Day

Last modified on

2024 Year 03 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048811


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name